10 stories mentioning LQDA
Every FINWIRES story that references LQDA, newest first.
Raman Singh, Director, on May 21, 2026, sold 29,494 shares in Liquidia (LQDA) for $1,773,436. Following the Form 4 filing with the SEC, Singh has control over a total of 38,755 common shares of the company, with 38,755 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926066417/xslF345X05/tm2615686-2_4seq1.xml
Roger Jeffs, Director, Chief Executive Officer, on May 21, 2026, sold 75,000 shares in Liquidia (LQDA) for $4,575,675. Following the Form 4 filing with the SEC, Jeffs has control over a total of 2,232,198 common shares of the company, with 1,137,508 shares held directly and 1,094,690 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926066415/xslF345X05/tm2615686-1_4seq1.xml
Roger Jeffs, Director, Chief Executive Officer, on May 13, 2026, sold 75,000 shares in Liquidia (LQDA) for $4,298,765. Following the Form 4 filing with the SEC, Jeffs has control over a total of 2,382,198 common shares of the company, with 1,137,508 shares held directly and 1,244,690 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926062852/xslF345X05/tm2614860-1_4seq1.xml
Healthcare stocks were rising premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.2% higher and the iShares Biotechnology ETF (IBB) up 0.4%.Moderna (MRNA) stock was up more than 8% after the company, according to Bloomberg, said it has been working on early stage vaccines targeting hantaviruses.Liquidia (LQDA) shares were up more than 3% after the company said it swung to Q1 earnings as revenue rose during the period.Zai Lab (ZLAB) received the US Food and Drug Administration's fast track designation for zocilurtatug pelitecan, or zoci, for the treatment of extrapulmonary neuroendocrine carcinomas, the company said. Zai Lab stock was up nearly 4% pre-bell.
Roger Jeffs, Director, Chief Executive Officer, on April 14, 2026, sold 53,300 shares in Liquidia (LQDA) for $2,143,323. Following the Form 4 filing with the SEC, Jeffs has control over a total of 2,626,128 common shares of the company, with 1,137,599 shares held directly and 1,488,529 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926044512/xslF345X05/tm2612047-2_4seq1.xml
Michael Kaseta, Chief Operating Officer and Chief Financial Officer, on April 14, 2026, sold 142,390 shares in Liquidia (LQDA) for $5,715,240. Following the Form 4 filing with the SEC, Kaseta has control over a total of 353,356 common shares of the company, with 353,356 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926044511/xslF345X05/tm2612047-1_4seq1.xml
Jason Adair, Chief Business Officer, on April 13, 2026, sold 7,301 shares in Liquidia (LQDA) for $280,139. Following the Form 4 filing with the SEC, Adair has control over a total of 215,426 common shares of the company, with 215,426 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926043271/xslF345X05/tm2611789-7_4seq1.xml
Scott Moomaw, Chief Commercial Officer, on April 13, 2026, sold 10,547 shares in Liquidia (LQDA) for $404,402. Following the Form 4 filing with the SEC, Moomaw has control over a total of 184,558 common shares of the company, with 184,558 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926043274/xslF345X05/tm2611789-8_4seq1.xml
Michael Kaseta, CFO and COO, on April 09, 2026, sold 133,789 shares in Liquidia (LQDA) for $5,383,388. Following the Form 4 filing with the SEC, Kaseta has control over a total of 411,855 common shares of the company, with 411,855 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926042710/xslF345X05/tm2611705-1_4seq1.xml
Roger Jeffs, Director, Chief Executive Officer, on April 09, 2026, sold 25,000 shares in Liquidia (LQDA) for $1,002,888. Following the Form 4 filing with the SEC, Jeffs has control over a total of 2,705,438 common shares of the company, with 1,142,176 shares held directly and 1,563,262 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926042711/xslF345X05/tm2611705-2_4seq1.xml